Chat with us, powered by LiveChat
Home Our Attorneys Christopher Branyik
Christopher Branyik

Christopher Branyik

Client Liaison

Focus: Mesothelioma and Asbestos

Phone: (212) 558-5500

Fax: (212) 344-5461

New York Office: 700 Broadway
New York, NY 10003

Get In Touch
Biography
Biography
Biography

Get to know Christopher

Education
  • B.S. in communications, Columbia College, Chicago, 1979.

Biography

Chris Branyik is a client liaison with Weitz & Luxenberg. A veteran with a decade’s experience communicating with clients and their families, Chris’ primary duty is to meet with a new client at the outset of his or her case to discuss concerns and goals.

Chris works principally with men and women who have been exposed to asbestos and need help with filing a lawsuit or receiving advice about their situation.

In a typical case, Chris will call to schedule an appointment with a new client. This meeting is an exchange of ideas and facts, with the new client explaining his or her case, and Chris explaining what Weitz & Luxenberg can do to help.

Chris will assist new clients in a variety of important areas. First, he will help the client research the sources of their asbestos exposure. Secondly, he will patiently explain the simple legal facts associated with the client’s case. Finally, Chris will share the details of Weitz and Luxenberg’s proud client track record and unique resources in legal services.

If, after working with Chris, the client is interested in working with Weitz & Luxenberg, Chris will work to match the new client with the attorney best suited to handle his or her case.

Chris represents Weitz & Luxenberg in the Western U.S., and is stationed in Chicago.

Chris has extensive experience working directly with clients and their families, having worked as a client liaison for 25 years in several different industries before joining Weitz & Luxenberg.

Education
  • B.S. in communications, Columbia College, Chicago, 1979.

Awards & Honors

Key Verdicts

Presentations & Publications

Request A Free Consultation

"*" indicates required fields

Disclaimer*
Your consent to contact is not required. To proceed without providing consent,  please call us at (855) 930-5906. 

  1. U.S. Food & Drug Administration. (2017, August 25). Medical Devices. Recalls, Corrections and Removals (Devices) Retrieved from
    https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/RecallsCorrectionsAndRemovals/default.htm
  2. U.S. Government Accountability Office. (2015, June 30). Medical Device Companies: Trends in Reported Net Sales and Profits Before and After Implementation of the Patient Protection and Affordable Care Act. Retrieved from
    http://www.gao.gov/products/GAO-15-635R
  3. U.S. Food & Drug Administration. (2017, January 25). Medical Devices. 510(k) Clearances. Retrieved from
    https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/
  4. U.S. Food & Drug Administration. (2017, June 30). MAUDE – Manufacturer and User Facility Device Experience. Retrieved from
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm
  5. The Wall Street Journal. (2014). How Morcellation, a Common Procedure, Spread Cancer in Hysterectomy Patients. Retrieved from
    http://www.wsj.com/morcellation
  6. U.S. Government Accountability Office. (2017, February). Medical Devices. Cancer Risk Led FDA to Warn Against Certain Uses of Power Morcellators and Recommend New Labeling. Retrieved from
    http://www.gao.gov/assets/690/682573.pdf
  7. U.S. Food & Drug Administration. (2017, January 25). Medical Devices. List of Device Recalls. Retrieved from https://www.fda.gov/medicaldevices/safety/listofrecalls/
  8. U.S. Food & Drug Administration. (2017, February 2). Medical Devices. Metal-on-Metal Hip Implant Systems. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/ucm241601.htm
  9. Berber, R., et al. (2016, May 18). Management of metal-on-metal hip implant patients: Who, when and how to revise? Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865716/
  10. U.S. Food & Drug Administration. (2016, November 25). Medical Devices. Metal-on-Metal Hip Implants: FDA Activities. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241769.htm
  11. U.S. Food & Drug Administration. (2017, February 8). Information for Patients Who Have Metal-on-Metal Hip Implants. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241766.htm#13
  12. U.S. Food & Drug Administration. (2015, April 10). Medical Devices. Concerns about Metal-on-Metal Hip Implants. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
  13. Oliveira, C.A., et al. (2014, November 28). Metallosis: A diagnosis not only in patients with metal-on-metal prostheses. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26937430
  14. U.S. Food & Drug Administration. (2015, April 10). Medical Devices. Concerns about Metal-on-Metal Hip Implants. Retrieved from https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
  15. Penn Medicine. Abramson Cancer Center. (n.d.). Types of Mesothelioma or Pleural Disease. Retrieved from https://webcache.googleusercontent.com/search?q=cache:GyCrbtitgHwJ:https://ora.ox.ac.uk/objects/uuid:842f7ea5-19a6-44b6-bc03-23a9e836a036/datastreams/content01+&cd=3&hl=en&ct=clnk&gl=us
  16. Drummond, J., et al. (2015, June 26). Metal-on-Metal Hip Arthroplasty: A Review of Adverse Reactions and Patient Management. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598667/
  17. Krochtengel, J. (2016, December 2). Huge Verdicts Won’t Spur Settlement Talks in J&J Hip MDL. Retrieved from https://www.law360.com/articles/868311/huge-verdicts-won-t-spur-settlement-talks-in-j-j-hip-mdl
  18. Koch, C.N., et al. (2016, October). Spontaneous Fractures of a Modern Modular Uncemented Femoral Stem. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27703419
  19. Stronach, B.M., et al. (2016, March). Failure of Emperion modular femoral stem with implant analysis. Retrieved from http://www.arthroplastytoday.org/article/S2352-3441(15)00080-1/fulltext
  20. Shah, R.R., et al. (2017, October). Alarmingly High Rate of Implant Fractures in One Modular Femoral Stem Design: A Comparison of Two Implants. Retrieved from http://www.arthroplastyjournal.org/article/S0883-5403(17)30470-9/fulltext
  21. Australian Orthopaedic Association National Joint Replacement Registry. South Australian Health and Medical Research Institute Ltd. (2016, September). Emperion Total Conventional Hip Investigation. Retrieved from https://aoanjrr.sahmri.com/documents/10180/277147/Emperion%20Femoral%20Stem
  22. Smith & Nephew Inc. (2016, November 15). Urgent Field Safety Notice: Medical Device Field Safety Corrective Action/Recall. Retrieved from http://www.bfarm.de/SharedDocs/Kundeninfos/EN/11/2016/09832-16_Kundeninfo_en.pdf;jsessionid=A90BEC524676E62D9943FE20B8C99B1C.1_cid350?__blob=publicationFile&v=1
  23. O’Sullivan, J. (2016, December 19). Stryker Adds Patients To $1B Hip Implant Settlement. Retrieved from https://www.law360.com/articles/874540/stryker-adds-patients-to-1b-hip-implant-settlement
  24. U.S. Food & Drug Administration. (2017, July 19). Class 2 Device Recall. Stryker LFIT Anatomic V40 Femoral Head. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=149782
  25. U.S. Judicial Panel on Multidistrict Litigation. (2017, April 5). In Re: Stryker Orthopaedics LFIT V40 Femoral Head Products Liability Litigation. MDL No. 2768. Retrieved from http://www.jpml.uscourts.gov/sites/jpml/files/MDL-2768-Initial_Transfer-03-17.pdf
  26. Ibid.
  27. Field, E. (2016, November 2). Wright Medical Technology Agrees to $240M Hip Implant Deal. Retrieved from https://www.law360.com/articles/858934
  28. U.S. Food & Drug Administration. (2015, October 2). Safety. Profemur Neck Varus/Valgus CoCr 8 Degree, Part number PHAC 1254 by MicroPort Orthopedics: Class I Recall - Unexpected Rate of Fractures After Surgery. Retrieved from https://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm465529.htm
  29. MicroPort. (2013, June 25). MicroPort Scientific Corporation and Wright Medical Group, Inc. Enter Into Definitive Agreement Under Which MicroPort Will Acquire Wright's OrthoRecon Business. Retrieved from http://www.microport.com.cn/en/media.php?curr_page=news_details&id=199
  30. U.S. Food & Drug Administration. (2009, June 24). Safety. Background and Definitions. Retrieved from https://www.fda.gov/Safety/Recalls/ucm165546.htm
  31. U.S. Food & Drug Administration. (2015, October 2). Safety. Profemur Neck Varus/Valgus CoCr 8 Degree, Part Number PHAC 1254 by MicroPort Orthopedics: Class I Recall – Unexpected Rate of Fractures After Surgery. Retrieved from https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm465529.htm
  32. U.S. National Library of Medicine. MedlinePlus. (2015, July 13). Risks of hip and knee replacement. Retrieved from https://medlineplus.gov/ency/patientinstructions/000375.htm
  33. U.S. Food & Drug Administration. (2017, July 19). Medical Device Recalls. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?start_search=1&event_id=55876
  34. U.S. Food & Drug Administration. (2017, July 19). Medical Device Recalls. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?start_search=1&event_id=57178
  35. U.S. Judicial Panel on Multidistrict Litigation. (2017, June 15). MDL Statistics Report – Distribution of Pending MDL Dockets by District (ILN). MDL-2272. Retrieved from http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-June-15-2017.pdf
  36. U.S. Food & Drug Administration. (2017, July 19). Class 2 Device Recall. Persona Trabecular Metal Tibial Plate/Persona TM Tibia. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?ID=133978
  37. Smith & Nephew, Inc. (2018, June 13). Urgent Field Safety Notice. Retrieved from https://www.mcgartland.com/wp-content/uploads/2018/07/Smith-Nephew-Field-Safety-Notice-Journey-BCS-Knee.pdf
  38. U.S. Food & Drug Administration. (2018, October 1). Class 2 Device Recall. Journey BCS Knee System. Retrieved from https://www.accessdata.fda.gov/SCRIPTs/cdrh/cfdocs/cfres/res.cfm?id=165170
  39. Ibid.
  40. Eisner, W. (2018, August 8). Orthopedics This Week. Safety Notice for S&N Journey BSC (sic) Knee. Retrieved from https://ryortho.com/breaking/safety-notice-for-sn-journey-bsc-knee/
  41. Ranawat, A. S. (2010, April 14). Revision Total Knee Replacement: Frequently Asked Questions. Retrieved from https://www.hss.edu/conditions_revision-total-knee-replacement-faqs.asp
  42. American Academy of Orthopaedic Surgeons. (2015, May). Revision Total Knee Replacement. Retrieved from https://orthoinfo.aaos.org/en/treatment/revision-total-knee-replacement/
  43. Bohsali, K., et al. (2017, February 1). Complications of Shoulder Arthroplasty. Retrieved from https://web.archive.org/web/20190903052402/http://journals.lww.com/jbjsjournal/Abstract/2017/02010/Complications_of_Shoulder_Arthroplasty.10.aspx
  44. U.S. Food & Drug Administration. (2017, April 4). Medical Devices. Hernia Surgical Mesh Implants. Retrieved from https://web.archive.org/web/20190903052402/https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/HerniaSurgicalMesh/default.htm
  45. U.S. Food & Drug Administration. (n.d.). Medical Devices. Surgical Mesh: FDA Safety Communication. Retrieved from https://web.archive.org/web/20190903052402/https://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm142636.htm
  46. Ibid.
  47. U.S. Food & Drug Administration. (2011, July 5). MAUDE Adverse Event Report: Atrium Medical Corporation Atrium C-QUR 4” x 6” Hernia Mesh. Retrieved from https://web.archive.org/web/20190903052402/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/detail.cfm?mdrfoi__id=2650980
  48. U.S. Food & Drug Administration. (2017, June 28). MAUDE Adverse Event Report: Davol Inc., Sub. C.R. Bard, Inc. Mesh-Ventralex Surgical Mesh. Retrieved from https://web.archive.org/web/20190903052402/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=6675252&pc=FTL
  49. U.S. Food & Drug Administration. (2017, May 22). MAUDE Adverse Event Report: Johnson & Johnson International Physiomesh Mesh, Surgical. Retrieved from https://web.archive.org/web/20190903052402/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=6642940&pc=FTL
  50. U.S. Food & Drug Administration. (2017, June 15). MAUDE Adverse Event Report: Covidien/Medtronic Parietex Progrip Mesh. Retrieved from https://web.archive.org/web/20190903052402/https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=5774864&pc=KDD